Phoenix Biotech Acquisiti... (PBAXW)
0.06
-0.01 (-7.69%)
At close: Feb 14, 2024, 7:33 PM
Company Description
No Company description available at the moment.
Phoenix Biotech Acquisition Corp.
| Country | n/a |
| IPO Date | n/a |
| Industry | Shell Companies |
| Sector | Financial Services |
| Employees | n/a |
| CEO | Christopher B. Ehrlich M.B.A. |
Contact Details
Address: No Address available No city data available, | |
| Website | n/a |
Stock Details
| Ticker Symbol | PBAXW |
| Exchange | NASDAQ |
| Fiscal Year | n/a |
| Reporting Currency | USD |
| CIK Code | 0001870404 |
| CUSIP Number | n/a |
| ISIN Number | n/a |
| Employer ID | 87-1088814 |
| SIC Code | 6770 |
Key Executives
| Name | Position |
|---|---|
| Christopher B. Ehrlich M.B.A. | Chief Executive Officer & Director |
| Daniel E. Geffken M.B.A. | Chief Financial Officer |
| Dr. Douglas Carl Fisher M.B.A., M.D. | President |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Apr 15, 2025 | 10-K | Annual Report |
| Apr 04, 2025 | SCHEDULE 13D/A | [Amend] Filing |
| Apr 04, 2025 | 4 | Filing |
| Apr 01, 2025 | NT 10-K | Filing |
| Mar 06, 2025 | 4 | Filing |
| Feb 26, 2025 | 4 | Filing |
| Feb 26, 2025 | 4 | Filing |
| Feb 26, 2025 | 4 | Filing |
| Feb 26, 2025 | 4 | Filing |
| Feb 26, 2025 | 4 | Filing |